Dose increases typically occur every four weeks, in 2.5 mg increments
Japanese Patient Studies The Japanese patient studies revealed similar patterns, with tirzepatide outperforming traditional GLP-1 receptor agonists in both weight management and glycemic control
Clinicians should carefully consider use in patients with significant motility disorders, inflammatory bowel disease with strictures, or severe chronic constipation
Our Process for Determining if You Are a Candidate for Tirzepatide in Rocklin, CA At California Concierge, our approach to determining if Tirzepatide is right for you is thorough and personalized: 1
If prescribed, your medication will be shipped discreetly to your door
Your initial consultation is a comprehensive discussion with our medical experts